Literature DB >> 8013527

Megakaryocytes: origin of bleeding and thrombotic disorders.

W Schneider1, N Gattermann.   

Abstract

Thrombocytes of lower vertebrates are nucleated diploid cells, which differentiate directly from stem cells without an interposed megakaryocytic maturation program. With increased complexity of circulatory systems and higher blood pressures, more efficient haemostasis was required. In higher vertebrates and man, megakaryocytes developed which, by way of endomitotic polyploidization, can amplify genes relevant for haemostasis and adapt platelets to different haemostatic demands. As endomitotic polyploidization is regulated by cytokines, it is also influenced by inflammatory or malignant cell growth. The responsiveness of the megakaryocyte system to various stimuli is a possible explanation for the high incidence of thrombohaemorrhagic and thromboembolic disorders in man. For example, thrombotic complications in tumour patients are due to pathologic overstimulation of megakaryocytes. Atherosclerosis is another process which may be caused by inappropriate stimulation of the megakaryocyte system. As this complication does not manifest itself during reproductive ages, it is not going to be corrected by evolution.

Entities:  

Mesh:

Year:  1994        PMID: 8013527     DOI: 10.1111/j.1365-2362.1994.tb02420.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  3 in total

Review 1.  Origins of the Vertebrate Erythro/Megakaryocytic System.

Authors:  Ondrej Svoboda; Petr Bartunek
Journal:  Biomed Res Int       Date:  2015-10-18       Impact factor: 3.411

2.  Inflammatory Indexes for Assessing the Severity and Disease Progression of Ulcerative Colitis: A Single-Center Retrospective Study.

Authors:  Hanyang Lin; Zhaohui Bai; Qiong Wu; Guiyang Chu; Yongguo Zhang; Xiaozhong Guo; Xingshun Qi
Journal:  Front Public Health       Date:  2022-03-10

3.  Transcriptome Profile of the Chicken Thrombocyte: New Implications as an Advanced Immune Effector Cell.

Authors:  Farzana Ferdous; Christopher Saski; William Bridges; Matthew Burns; Heather Dunn; Kathryn Elliott; Thomas R Scott
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.